Vitamin C buyers certified to bring class action suit against Chinese pharma companies
U.S. District Judge Brian M. Cogan certified a class of Vitamin C buyers to bring a price-fixing suit against Chinese pharmaceutical companies. The defendants North China Pharmaceutical Co., Aland (Jiangsu) Nutraceutical Co., Northeast Pharmaceutical Co. and Weisheng Pharmaceutical Co. were found to have more than 60 percent world market share for Vitamin C.
New Jersey food company Ranis Co. was appointed to represent the group seeking damages. Texas maker of animal feed additives Animal Science Products Inc. is the class representative for the group requesting an injunction.
Source: Bloomberg
Related content: Duking It Out in Antitrust Price-Fixing: Class Actions After Dukes (Jay Himes & William Reiss, Labaton Sucharow)
Featured News
FTC Urged to Enforce Rarely Used Antitrust Law Against Retail Giants
Mar 28, 2024 by
CPI
UK’s Fingleton Bolsters Team with New Additions
Mar 28, 2024 by
CPI
Britain’s Competition Regulator Clears Aviva’s Acquisition of AIG Life UK
Mar 28, 2024 by
CPI
White House Implements New AI Safeguards to Protect Rights and Safety
Mar 28, 2024 by
CPI
Denver Court Sets August Date for Kroger-Albertsons Merger Showdown
Mar 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI